Evidence for a suppression of apoptosis in early postnatal life

Acta Obstetricia et Gynecologica Scandinavica

Volumn 80, Issue 11, 2001, Pages 994-997

  Malamitsi Puchner, A ^a   Sarandakou, A ^a   Tziotis, J ^a   Trikka, P ^a   Creatsas, G ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

Apoptosis; Early postnatal life; Neonate; Soluble forms of Fas Fas ligand; TNFR1 TNF ; Umbilical cord

Indexed keywords

FAS ANTIGEN; LIGAND; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

APOPTOSIS; ARTICLE; BLOOD LEVEL; DOWN REGULATION; ENZYME IMMUNOASSAY; FEMALE; GESTATIONAL AGE; HUMAN; HUMAN EXPERIMENT; MALE; NEWBORN; NORMAL HUMAN; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL;

ANTIGENS, CD95; APOPTOSIS; DOWN-REGULATION; FAS LIGAND PROTEIN; FEMALE; FETAL BLOOD; HUMANS; INFANT, NEWBORN; MALE; MEMBRANE GLYCOPROTEINS; PREGNANCY; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035168026     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0412.2001.801104.x     Document Type: Article

References (33)

1. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics
2. The Fas death factor
3. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen
4. Monoclonal antibody-mediated tumor regression by induction of apoptosis
5. APO-1 induces apoptosis of leukemia cells from patients with ATL
6. Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals
7. Fas ligand mediates activation-induced cell death in human T lymphocytes
8. Fas mediated cytotoxicity by freshly isolated natural killer cells
9. Differential expression of Fas (CD 95) and Fas ligand on normal human phagocytes: Implications for the regulation of apoptosis in neutrophils
10. Expression of the Fas ligand in T-cell lineage
11. Fas ligand in human serum
12. A role for CD95 ligand in preventing graft rejection
13. Fas ligand induces apoptosis as a mechanism of immune privilege
14. Apoptosis by death factor
15. Membrane Fas ligand kills human peripheral blood T lymphocytes and soluble Fas ligand blocks the killing
16. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor
17. The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation and death
18. Processing of tumor necrosis factor-α precursor by metalloproteinases
19. To die or not to die. An overview of apoptosis and its role in disease
20. An N-terminal domain shared by Fas/Apo-1 (CD95) soluble variants prevents cell death in vitro
21. The active form of tumor necrosis factor is a trimer
22. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor α in vitro and in vivo
23. Downregulation of Fas ligand by shedding
24. Serum concentrations of soluble Fas antigen and soluble Fas ligand in mother and newborn
25. Programmed cell death in animal development
26. Apoptosis in development and disease of the nervous system. 1. Naturally occurring cell death in the developing nervous system
27. Localization of Bcl-2 in the human fetal mullerian tract
28. The role of apoptosis in normal and abnormal embryonic development
29. Apoptosis and Fas expression in human fetal membranes
30. Increased placental apoptosis in intrauterine growth restriction
31. The death domain kinase RIP mediates the TNF-induced F-kappaB signal
32. Mitochondrial DNA depletion in children
33. Neurod2 is necessary for deveopment and survival of central nervous system neurons